Blood test aims to Fine-Tune Anti-Rejection drugs for kidney transplants
NCT ID NCT01424345
First seen Mar 26, 2026 · Last updated May 07, 2026 · Updated 5 times
Summary
This study looked at whether a special blood test called ImmuKnow could help doctors better manage immunosuppressant drugs in new kidney transplant patients. The goal was to reduce infections and prevent organ rejection. Only 4 people took part before the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT IMMUNOSUPPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CAMC
Charleston, West Virginia, 25301, United States
Conditions
Explore the condition pages connected to this study.